MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Subject-specific investigation of pathways underlying therapeutic outcomes of deep brain stimulation for Essential Tremor

    R. Butler, M. Blumenfeld, A. Brinda, M. Bryants, D. Sullivan, S. Pandey, T. Palnitkar, R. Patriat, J. Vitek, L. Schrock, K. Gagesch, K. Domingo, T. Orcutt, N. Harel, J. Matsumoto, S. Cooper, M. Johnson (Minneapolis, USA)

    Objective: To relate subject-specific pathway activation models of motor thalamic deep brain stimulation (DBS) to clinical outcomes in patients with Essential Tremor (ET). Background: Computational…
  • 2023 International Congress

    The Dystonic Drive – A Systematic Review on Coherence Analysis in Dystonia

    S. Lagerweij, M. Smit, L. Centen, M. van Egmond, JW. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: To perform a systematic review on coherence analysis in dystonia. We focus on different modalities and describe the relation of abnormal coherent frequency bands…
  • 2023 International Congress

    Remote monitoring of physical activity in Progressive Supranuclear Palsy (PSP) using wearable sensors

    AM. Wills, R. Mishra, M. Sharma, AJ. Hall, J. Casado, R. Cole, A. Vaziri, A. Pantelyat (Boston, USA)

    Objective: To remotely monitor physical activity in people with PSP and to correlate it with disease progression on the modified PSP Rating Scale (mPSPRS-21). Background:…
  • 2023 International Congress

    Disease progression of spinocerebellar ataxia types 1, 2, 3, and 6 before and after ataxia onset: a joint analysis of two longitudinal cohort studies

    H. Jacobi, T. Schaprian, M. Schmid, T. Klockgether (Heidelberg, Germany)

    Objective: The aim was to model the evolution of ataxia and neurological symptoms in SCA1, SCA2, SCA3, and SCA6 over the entire disease span and…
  • 2023 International Congress

    Application of multi-parametric diffusion MRI in detecting visual disturbances in advanced Parkinson’s disease population

    K. Shivok, I. Ailes, M. Syed, I. Shelley, A. Alhussein, I. Fayed, T-W. Liang, C. Wu, A. Sharan, F. Mohamed, R. Sergott, L. Krisa, M. Alizadeh (Philadelphia, USA)

    Objective: We aimed to identify differences in multi-parametric diffusion indices (DTI, NODDI, and DKI) between Parkinson’s disease patients with visual disturbances and those without. Background:…
  • 2023 International Congress

    Autosomal dominant Parkinson’s disease caused by SNCA p.E46K variant in family with Russian ancestry: A case report

    K. Senkevich, I. Miliukhina, A. Zhuravlev, M. Shumilova, M. Beletskaia, A. Tyurin, M. Grunina, A. Rybakov, J. Ahmad, F. Asayesh, A. Timofeeva, Z. Gan-Or, A. Emelyanov, S. Pchelina (Montreal, Canada)

    Objective: To report a family with autosomal dominant Parkinson’s disease (PD) with SNCA p.E46K variant. Background: Alpha-synuclein, encoded by SNCA, is a part of Lewy…
  • 2023 International Congress

    Clebopride-induced Rabbit Syndrome: A Case Report.

    IA. Ortiz-Marroquin, E. Valdez-Rodriguez, V. Rodriguez-Martinez, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: This report aims to present a case of rabbit syndrome attributed to clebopride and to highlight the importance of considering nonneuroleptic drugs as a…
  • 2023 International Congress

    Trends in the evaluation and management of constipation in patients with Parkinson disease

    L. Deuel, W. Wright, E. Houston (Burlington, USA)

    Objective: Explore common evaluation and management strategies for constipation in patients with Parkinson disease (PD) at a tertiary center. Background: PD is diagnosed based on…
  • 2023 International Congress

    The diagnosis value of dopaminergic responsiveness of Parkinson’s disease: a systematic review and meta-analysis

    WY. Kou, HH. Cai, FT. Feng (beijiing, China)

    Objective: aimed to confirm the diagnostic value/accuracy of levodopa and/or apomorphine challenge test in parkinsonian syndromes (PDS) to assess their value in the diagnosis of…
  • 2023 International Congress

    Case report on heterozygous OPA3 gene mutation causing ataxia

    J. Ng, T. Stiep (San Francisco, USA)

    Objective: To describe a case of adult-onset ataxia with a heterozygous p.Lys10Asn OPA3 mutation. Background: Mutations in the OPA3 gene, which encodes a mitochondrial membrane…
  • « Previous Page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley